Bortezomib maintenance for the treatment of Monoclonal Gammopathy of Renal Significance
Monoclonal gammopathy of renal significance (MGRS) defines renal disease resulting from monoclonal proteins that are secreted from clonal B cells, that does not meet criteria for lymphoma or multiple myeloma. Recognizing MGRS in clinical practice is important because renal outcomes are poor and trea...
Main Authors: | Holly Lee, Peter Duggan, Ernesta Paola Neri, Jason Tay, Victor Jimenez Zepeda |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2019-01-01
|
Series: | Mediterranean Journal of Hematology and Infectious Diseases |
Online Access: | https://www.mjhid.org/index.php/mjhid/article/view/3684 |
Similar Items
-
Monoclonal Gammopathy of Renal Significance: Clinical and Histological Efficacy of a Bortezomib-Based Regimen
by: Giacomo Quattrocchio, et al.
Published: (2020-12-01) -
The Monoclonal Gammopathies of Renal Significance
by: Patricia Kleinova, et al.
Published: (2024-08-01) -
Monoclonal gammopathies of renal significance
by: Fernando Caravaca-Fontán, et al.
Published: (2017-09-01) -
Unusual Cases of Monoclonal Gammopathy of Renal Significance
by: Anjellica Chen, et al.
Published: (2024-01-01) -
Pathophysiology and management of monoclonal gammopathy of renal significance
by: Ankur Jain, et al.
Published: (2019-08-01)